Total knee arthroplasty is associated with moderate to severe postoperative pain and may result to prolong hospital stay, decrease patient satisfaction, prolong rehabilitaion function. postoperative pain, steroid injection, total knee arthroplasty, intraarticular injection, periarticular injection
Conditions
Interventions
-DIPROSPAN (5 mg betamethasone dipropionate and 2 mg betamethasone sodium phosphate) is injected at postoperative day 3 before discharge via epidural catheter (Perifix B Bruan Medical) which was appli
Experimental Procedure/Surgery,Active Comparator Procedure/Surgery
Intraarticular steroid injection,Periarticular steroid injection
Sponsors
King Chulalongkorn Memorial Hospital
Eligibility
Sex/Gender
All
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age greater than or equal to 50 years old 2.Knee osteoarthritis Kellgren-Lawrence (KL) grade 3 or 4 3.Undergoing unilateral primary total knee arthroplasty (TKA)
Exclusion criteria
Exclusion criteria: 1.Known allergy to the drugs used in this trial. 2.Previous surgery on the affected limb within 1 year. 3.Major co-morbidity precluding aerobic exercise at 50- 60% maximum heart rate 4.Decreased mobility due to non-joint-related factors e.g. Parkinson disease 5. Inability to communicate or unwilling to give informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analog scale at 1,3 days and 2,6,12 weeks after surgery Visual analog scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Range of flexion motion 1 day, 3 days, 2,6,12 weeks measure a flexion angle of the post operative knee,celebrex consumption at 2 weeks after surgery number of tablet,Functional outcome at 2,6,12 weeks after surgery Knee society score | — |
Countries
Thailand
Contacts
Public ContactBhupaak Engkapawastr
Orthopaedic department
Outcome results
None listed